FDA Warns Healthcare Providers Against Administering Hydroxychloroquine Or Chloroquine In Combination With Remdesivir

June 16, 2020

Reuters (6/15, Roy) reports that on Monday, the FDA “issued a warning to healthcare providers against administering malaria drug hydroxychloroquine or chloroquine in combination with” the “experimental COVID-19 drug, remdesivir.” The FDA, “based on data f...